Literature DB >> 26952810

Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.

Wei Lv1, Na Chen1, Yanliang Lin1, Hongyan Ma1, Yongwei Ruan1, Zhiwei Li1, Xungeng Li1, Xiaohua Pan1, Xingsong Tian2.   

Abstract

Macrophage migration inhibitory factor (MIF) is up-regulated in diverse solid tumors and acts as the critical link between immune response and tumorigenesis. In this study, we demonstrated that MIF overexpression promoted migration of breast cancer cells by elevating TLR4 expression. Further investigation evidenced that MIF induced ROS generation. MIF-induced ROS led to ERK phosphorylation, which facilitated HMGB1 release from the nucleus to the cytoplasm. MIF overexpression also induced caveolin-1 phosphorylation. Caveolin-1 phosphorylation contributed to HMGB1 secretion from the cytoplasm to the extracellular matrix. The extracellular HMGB1 activated TLR4 signaling including NF-κB phosphorylation, which was responsible for the transcription of Snail and Twist as well as MMP2 activation. Furthermore, MIF-induced caveolin-1-dependent HMGB1 secretion might control the recruitment of CD11b+ immune cells. Our data suggested that MIF affected the intrinsic properties of tumors and the host immune response in tumor microenvironment by regulating the TLR4/HMGB1 axis, leading to metastasis of breast cancer.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Breast cancer; HMGB1; Macrophage migration inhibitory factor (MIF); Metastasis; TLR4

Mesh:

Substances:

Year:  2016        PMID: 26952810     DOI: 10.1016/j.canlet.2016.02.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.

Authors:  Guangjie Wang; Chuanbin Li; Yashou Liu; Lei Xia
Journal:  Neurotox Res       Date:  2018-12-01       Impact factor: 3.911

2.  [Macrophage migration inhibitory factor promotes lung fibrosis via reactive oxygen species-mediated up-regulation of aerobic glycolysis].

Authors:  Yun Gao; Yu Chen; Huaping Yu; Haibing Lan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

3.  Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers.

Authors:  Bahareh Kashani; Zahra Zandi; Mohammad Reza Karimzadeh; Davood Bashash; Ali Nasrollahzadeh; Seyed H Ghaffari
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

4.  18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.

Authors:  Kirsten M Reeves; Patrick N Song; Anna G Sorace; Benjamin M Larimer; Allyson Angermeier; Deborah Della Manna; Yufeng Li; Jianbo Wang; Eddy S Yang
Journal:  Clin Cancer Res       Date:  2021-10-06       Impact factor: 13.801

Review 5.  Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.

Authors:  Efthalia Angelopoulou; Christina Piperi; Christos Adamopoulos; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2016-06-04       Impact factor: 4.599

6.  Macrophage migration inhibitory factor mediates protease-activated receptor 4-induced bladder pain through urothelial high mobility group box 1.

Authors:  Fei Ma; Dimitrios E Kouzoukas; Katherine L Meyer-Siegler; David E Hunt; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  Physiol Rep       Date:  2017-12

7.  Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.

Authors:  Xiangrong Chen; Shukai Wu; Chunnuan Chen; Baoyuan Xie; Zhongning Fang; Weipeng Hu; Junyan Chen; Huangde Fu; Hefan He
Journal:  J Neuroinflammation       Date:  2017-07-24       Impact factor: 8.322

8.  14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.

Authors:  Jing Luo; Jian-Feng Yao; Xiao-Fei Deng; Xiao-Dan Zheng; Min Jia; Yue-Qin Wang; Yan Huang; Jian-Hua Zhu
Journal:  J Exp Clin Cancer Res       Date:  2018-02-09

Review 9.  Emerging role of HMGB1 in lung diseases: friend or foe.

Authors:  Junying Ding; Xuran Cui; Qingquan Liu
Journal:  J Cell Mol Med       Date:  2016-12-31       Impact factor: 5.310

Review 10.  Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.

Authors:  Sha-Sha Wang; Xiao Cen; Xin-Hua Liang; Ya-Ling Tang
Journal:  Oncotarget       Date:  2017-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.